4-2271372-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_020972.3(ZFYVE28):c.2471C>T(p.Thr824Met) variant causes a missense change. The variant allele was found at a frequency of 0.000105 in 1,612,586 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00041 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000073 ( 0 hom. )
Consequence
ZFYVE28
NM_020972.3 missense
NM_020972.3 missense
Scores
2
17
Clinical Significance
Conservation
PhyloP100: 4.83
Genes affected
ZFYVE28 (HGNC:29334): (zinc finger FYVE-type containing 28) Enables phosphatidylinositol-3-phosphate binding activity. Involved in negative regulation of epidermal growth factor-activated receptor activity. Located in cytosol and early endosome membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.017882198).
BP6
Variant 4-2271372-G-A is Benign according to our data. Variant chr4-2271372-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2386421.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZFYVE28 | NM_020972.3 | c.2471C>T | p.Thr824Met | missense_variant | 12/13 | ENST00000290974.7 | NP_066023.2 | |
ZFYVE28 | NM_001172656.2 | c.2381C>T | p.Thr794Met | missense_variant | 11/12 | NP_001166127.1 | ||
ZFYVE28 | NM_001172659.2 | c.2261C>T | p.Thr754Met | missense_variant | 12/13 | NP_001166130.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZFYVE28 | ENST00000290974.7 | c.2471C>T | p.Thr824Met | missense_variant | 12/13 | 1 | NM_020972.3 | ENSP00000290974 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152160Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
63
AN:
152160
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000114 AC: 28AN: 246188Hom.: 0 AF XY: 0.000112 AC XY: 15AN XY: 134258
GnomAD3 exomes
AF:
AC:
28
AN:
246188
Hom.:
AF XY:
AC XY:
15
AN XY:
134258
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000733 AC: 107AN: 1460308Hom.: 0 Cov.: 31 AF XY: 0.0000743 AC XY: 54AN XY: 726478
GnomAD4 exome
AF:
AC:
107
AN:
1460308
Hom.:
Cov.:
31
AF XY:
AC XY:
54
AN XY:
726478
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000414 AC: 63AN: 152278Hom.: 0 Cov.: 34 AF XY: 0.000282 AC XY: 21AN XY: 74444
GnomAD4 genome
AF:
AC:
63
AN:
152278
Hom.:
Cov.:
34
AF XY:
AC XY:
21
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
11
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;.;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N
REVEL
Benign
Sift
Benign
T;T;T;T
Sift4G
Benign
T;T;T;T
Polyphen
1.0, 0.55
.;D;P;.
Vest4
MVP
MPC
0.069
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at